Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Haematologica|October 16, 2012
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesisZhangguo Chen, Catherine T Yan, Yali Dou, et al.The Journal of Biological Chemistry|December 1, 2001
Agonist-induced internalization of the platelet-activating factor receptor is dependent on arrestins but independent of G-protein activation. Role of the C terminus and the (D/N)PXXY motifZhangguo Chen, Denis J Dupré, Christian Le Gouill, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 27, 2015
Imbalanced PTEN and PI3K Signaling Impairs Class Switch RecombinationZhangguo Chen, Andrew Getahun, Xiaomi Chen, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2018
TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 ActivationRachel A Woolaver, Xiaoguang Wang, Yonatan Dollin, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2016
Interplay between Target Sequences and Repair Pathways Determines Distinct Outcomes of AID-Initiated LesionsZhangguo Chen, Maxwell D Eder, Mihret T Elos, et al.Cell Death & Disease|September 7, 2023
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugsMonika Vashisht, Huaibin Ge, Jessy John, et al.Haematologica|December 9, 2017
Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibitionXiaoguang Wang, Zhangguo Chen, Ameet K Mishra, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2026
Pre-existing TCR clones drive major pathological responses in HNSCC patients treated with dual immune checkpoint inhibitorsHuaibin Ge, Housaiyin Li, Aditi Kulkarni, et al.Molecular Carcinogenesis|February 5, 2020
Tumor immune microenvironment in head and neck cancersSamantha M Y Chen, Alexandra L Krinsky, Rachel A Woolaver, et al.Protein & Cell|March 13, 2020
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphomaXiaoguang Wang, Brittany C Waschke, Rachel A Woolaver, et al.Pageof 5